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ASD closure performed between 2015 and 2017. The study population was divided into 2 groups: 37 patients below 50 years of age (median [range] age, 34 [18-45] years) were included in group 1 and 37 patients above 50 years of age (median [range] age, 58 [50-72] years), in group 2. We collected data on selected clini cal characteristics, heart catheterization, and echocardiography results (TABLE 1). The balloon stretched diameter of ASD was measured in 24 patients from group 1 and 24 from group 2. Applying a technique which was described elsewhere, 6 the following atrial septal occlud ers were used: 40 Hyperion (Shanghai Shape Memory Alloy Co, Shanghai, China), 21 Heart R (Lifetech Scientific Corporation, Shenzen, China), 6 Cera (Lifetech Scientific Corporation, Shenzen, China), and 7 Cocoon (Vascular In novations, Nonthaburi, Thailand) occluders. To minimize nickel release to serum, the fol lowing occluders have different protective lay ers: preoxidized nitinol in Hyperion, titani um nitride in Cera, and platinum in Cocoon. The Heart R occluder is produced without any protective layer on the nitinol wire. The appli cation of the above mentioned devices depend ed on its availability (results of conducted ten ders). Patients in whom the ASO (Abbott Med ical, Plymouth, Minnesota, United States) and Figulla (Occlutech GmbH, Jena, Germany) oc cluders were used in this period were exclud ed from the study in order to ensure homoge neity of the sample.
Introduction Transcatheter closure of atri al septal defect (ASD) type II can be safely per formed in children and adults. 1, 2 Since the im plementation of the Amplatzer septal occluder (ASO) in 1997, many similar nitinol wire mesh Amplatzer like occluders have been developed. Nitinol is an alloy of nickel and titanium. Stud ies revealed a rise in nickel serum concentration, especially in the first 3 months after the ASO im plantation. 3, 4 To prevent this phenomenon as sociated with the use of several Amplatzer like occluders (also the ASO from 2014), different methods to pretreat nitinol wires were applied.
The literature on the use of Chinese and Thai occluders for percutaneous ASD closure is scarce. 5 All these Amplatzer like occluders are very similar in shape, dimensions, struc ture of the delivery system, and the technique of implantation.
We described our experience with ASD clo sure in adults patients with the ASO devices elsewhere. 6 However, to our best knowledge, this is the first study on ASD closure with the use of different nitinol wire devices (Chinese and Thai) with and without a protective nitinol layer.
Methods Between 1997 and 2018, over 1800 patients (children and adults) underwent trans catheter closure of interatrial septum in our center, performed with different nitinol wire mesh occluders with and without a protective layer. 5 In this study, we included 74 subsequent adult patients with a history of percutaneous Results and discussion Transcatheter ASD closure was successfully performed in 73 out of the 74 patients (98.6%). In 1 patient from group 1 with relatively large ASD (treated with the 30mm Hyperion occluder), the procedure was discontinued due to unfavorable morphol ogy of the defect. The device was safely removed and the patient was referred for elective surgi cal closure of the defect.
While ASD (measured on transesophageal echocardiography) and applied devices' diam eters were similar in both groups, mean pul monary arterial pressure (measured directly in the catheterization laboratory) was higher in older patients (group 2). Left ventricular ejec tion fraction was lower in group 2 (the difference was not significant) as shown in TABLE 1. All nitinol wire mesh occluders (with and without a protective layer) were similarly effi cient with no difference in complication rate (no thrombosis, erosion, rupture, early or late embolization was observed). The fact that the de livery systems of Amplatzer like occluders are Patients were scheduled for a routine check up in the outpatient clinic 1, 6, and 12 months after ASD closure and yearly thereafter; 9 patients were lost to follow up. The median (range) follow up was 27 (4-39) months. The researchers contacted patients by phone to assess their physical condition using the New York Heart Association (NYHA) class. Pa tients' subjective view on that aspect was also elic ited by asking, among others, the question "How do you evaluate your physical well being after ASD closure?" with 5 possible answers: much better, bet ter, the same, worse, much worse. The study proto col was approved by the institutional review board.
Statistical analysis Statistical analysis was per formed with the use of the Statistica 12 software (TIBCO, Palo Alto, California, United States). P values less than 0.05 were considered signifi cant. Distribution of all variables was assessed with the Shapiro-Wilk test. Based on its results, the t test or Mann-Whitney test was used to compare numerical variables. Categorical vari ables were compared using the χ 2 test. 1 Selected clinical characteristics, data on heart catheterization, and echocardiography (before closure) in adult patients in whom atrial septal defect was closed percutaneously at the age below 50 years (group 1) or above (group 2) using nitinol wire mesh occluders with and without a protective layer
Parameter
All patients Group 1 (n = 37) Group 2 (n = 37) P value of a nitinol occluder due to nickel allergy; how ever, patients with severe allergy might benefit from the implantation of different Amplatzer like occluders with protective layers.
Limitations The retrospective nature and the small number of patients are the main lim itations of our study.
Conclusions Transcatheter closure of ASD in adult patients below and above the age of 50 years is a safe and effective procedure. The application of different Chinese and Thai nitinol wire occluders (with or without a pro tective layer) has similar effectiveness in this population.
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ACKNOWLEDGMENTS We would like to thank Weronika Duk and Katarzyna Potyka from the Student Research Group for their help in collecting the follow--up data. generally 2-3 F larger than those of the ASO is less important in adults than in preschool chil dren. 1, 5 The rates of periprocedural complications and procedural difficulties (reflected in the fluo roscopic time) were similar in both groups (TABLE 1) . In group 2, there were 3 patients with mild resid ual shunt diagnosed after the procedure by trans thoracic echocardiography, which disappeared at 1month follow up. We observed substantial cardiac remodeling that involved a decrease in the right ventricular diameter (RVD) and right to left ventricular end diastolic diameter ratio. The mean (SD) decrease of the RVD was from 3.43 (0.72) to 2.8 (0.6) cm in group 1 (t test, P <0.05) and from 3.75 (0.82) to 3.12 (0.7) cm in group 2 (t test, P <0.05). The right ventricu lar diameter (RVD) and right to left ventricu lar enddiastolic diameter ratio decreased from 0.8 (0.2) to 0.62 (0.1) in group 1 (t test, P <0.05) and from 0.85 (0.2) to 0.69 (0.21) in group 2 (t test, P <0.05).
CONFLICT OF INTEREST
After the procedure, the percentage of pa tients with NYHA class I raised from 28.6% to 82.1% in group 1 and from 9.5% to 66.7% in group 2.
Older patients (group 2) seemed to have a bet ter subjective opinion about the change in their physical function than younger adults; 60.7% of the patients in group 1 felt "better" or "much better" after ASD closure, whereas the same answers were given by 76.2% of the patients in group 2 (difference not significant).
Although safety and effectiveness of ASD clo sure in the elderly has already been document ed, 6,7 all previous studies were based on the ASO devices. Moreover, our paper presents an un dervalued and rarely described 7 aspect of phys ical function, cardiac remodeling, and quality of life after ASD closure in this population. To our best knowledge, there is no report that compares the safety and efficacy of ASD closure in young er and older adults performed with so many dif ferent devices.
Nickel allergy is estimated to be near 10% in the general population. 3 Cases requiring explan tation of ASO were reported in the literature. 4 We have not observed any symptoms of nickel allergy in our cohort, although we used occlud ers with bare nitinol wires (Heart R) as well as with a protective layer (Hyperion, Cera, Cocoon). Skin allergy to nickel does not equate adverse effects after device implantation and the mech anism of intracardiac hypersensitivity to nick el differs from skin allergy. 8 However, based on reports on acute reactions requiring explanta tion of the device, 4 we believe that testing a skin reaction to nickel (in form of a nitinol occlud er worn as a necklace) in patients with known allergy is helpful in clinical practice. It may ex clude patients with severe allergy who might develop an acute reaction to the occluder. We did not report a case requiring the explantation
